You can’t argue against facts.
Highlighting facts and missteps is not disparaging, it’s the truth. Just one single example:
I wonder out loud if any people felt misled about the conjunctivitis dream.
2013 CEO via ASX release:“SPL7013 has the potential to be a first-in-class anti-viral agent for viral conjunctivitis (VC)” ~ a direct quote from CEO !!
”A global market of US$700m exists for effective VC treatments” ~ a direct quote from CEO !!!
”Based on feedback from potential partners and clinicians this opportunity is being advanced..” - a direct quote from CEO !!
2014:
2015:
2016:
2017:
2018:
2019:
2020:
2021:
At the 2021 Starpharma AGM during Q&A with the CEO, shareholders were made aware that SPL7013 and viral-conjunctivitis was now not a priority.
This is truly shameful. But this is quite typical of what Starpharma do, and continue to do. Hello … the Indian distribution deal which supposedly was well advanced in partnering discussions for Viraleze. Still waiting…
DYOR
- Forums
- ASX - By Stock
- SPL
- Watch out disparaging and defamatory posters
Watch out disparaging and defamatory posters
-
- There are more pages in this discussion • 11 more messages in this thread...
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.9¢ |
Change
0.001(1.02%) |
Mkt cap ! $40.41M |
Open | High | Low | Value | Volume |
9.5¢ | 9.9¢ | 9.5¢ | $6.373K | 65.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17939 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 58065 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17939 | 0.099 |
2 | 20102 | 0.098 |
1 | 6185 | 0.097 |
2 | 528090 | 0.095 |
3 | 40638 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 58065 | 5 |
0.105 | 143452 | 5 |
0.110 | 114609 | 7 |
0.115 | 77331 | 6 |
0.120 | 89055 | 5 |
Last trade - 14.48pm 11/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |